Recent Trends and Methods in Antimicrobial Drug Discovery from Plant Sources

Review Article

Austin J Microbiol. 2015;1(1): 1002.

Recent Trends and Methods in Antimicrobial Drug Discovery from Plant Sources

Bakht Nasir, Humaira Fatima, Madiha Ahmad and Ihsan-ul-Haq*

Department of Pharmacy, Faculty of Biological Sciences,Quaid-i-Azam University, Islamabad 45320, Pakistan

*Corresponding author: Ihsan-ul-Haq, Department of Pharmacy, Quaid-i-Azam University, Islamabad 45320, Pakistan

Received: November 25, 2014; Accepted: March 19, 2015; Published: March 20, 2015

Abstract

Natural products especially plants represent an inexhaustible reservoir of novel molecules for new drug discovery. Plant derived crude extracts and pure compounds have a long history of management and cure of various ailments. The resurgence of resistant microbial strains and emergence of newer and more lethal infections has called for the need to acquire unique antimicrobials. Standardized tools and techniques are therefore inevitable for identification, isolation, evaluation and authentication of true antimicrobial capabilities of various phytochemicals. This review focuses on classical and advanced extract preparation techniques. The different methods of assessing antimicrobial capabilities of biological extracts along with their advantages and limitations have also been discussed. The variations and modifications reported by different researchers in the existing protocols along with their contributions in bioprospecting of pharmacologically active moieties have also been documented. In vitro antimicrobial assessment methodologies are wellestablished and have quite extensively served the purpose but in order to exploit the true potential of plants as a source of antimicrobial compounds, the need of establishing standardized in vivo testing protocols and determining valid correlation with in vitro efficacy result is mandatory.

Keywords: Antimicrobial susceptibility testing; Antimicrobials; Natural products; Medicinal plants; Phytochemicals

Abbreviations

AST: Antimicrobial Susceptibility Testing; NAPRALERT: Natural Products Alert; PSM: Plants Secondary Metabolites; SFE: Supercritical Fluid Extraction; MIC: Minimum Inhibitory Concentration; EUCAST: European Committee on Antimicrobial Susceptibility Testing; NCCLS: National Committee for Clinical Laboratory Standards; CLSI: Clinical and Laboratory Standards Institute; BSAC: British Society for Antimicrobial Chemotherapy; PDM: Paper Disc Method; CFU: Colony Forming Unit; TLC: Thin Layer Chromatography; FDA: Food and Drug Administration; ICAAC: Inter Science Conference on Antimicrobial Agents and Chemotherapy

Introduction

The interest in natural product research has revived in recent years due to the failure of alternative drug discovery methods to deliver many lead compounds in key therapeutic areas such as antiinfective, immunosuppression, and metabolic diseases. Natural product research continues to explore a range of lead structures, which may be used as templates for the development of new drugs by the pharmaceutical industry. The importance of natural products in providing a source of new pharmaceutical compounds cannot be denied [1].

Historically, plants have provided a source of inspiration for novel drug compounds, as the contributions to human health and well being made by plant-derived medicine have been outstanding. They may either become the base for the development of a natural blueprint for new drug discovery or a phytomedicine to be used for the treatment of diseases [2]. The World Health Organization reported that 80% of world’s population rely chiefly on traditional medicine, and a major part of the traditional therapies involve the use of plant extracts or their active constituents (WHO, 1993). The extensive use of antimicrobial drugs has resulted in the development of resistance by microbes against many antibiotics. So, this has created a serious clinical problem in the treatment of infectious diseases [3]. Apart from this, there are other concerns like serious adverse effects and safety problems associated with antibiotics. Therefore there is a definite need to develop alternative antimicrobial drugs for the treatment of prevailing infectious diseases.

Medicinal plants have been used for centuries as remedy for human ailments and they provide a cheaper and safer source of biologically active chemical compounds as antimicrobial agents. The antimicrobial properties of many plants have been investigated and they are also used extensively in daily clinical practice. Ethnopharmacologists, botanists, microbiologists, and naturalproduct chemists are searching the world for phytochemicals which could be developed for the treatment of infectious diseases [4]. Only a small number, out of several hundred thousand species of medicinal plants around the globe, have been investigated both phytochemically and pharmacologically [5]. Therefore, the methods required to evaluate the efficacy and potency of such a large number of potentially important medicinal plants and to prove their antimicrobial worth need to be efficient and well validated. The first step towards new antiinfective drug development is the Microbial Susceptibility Test (MST). It is an essential technique used in pathology to determine resistance of microbial strains to antimicrobials, and in ethnopharmacology research it is used to determine the efficacy of novel and medically important antimicrobials. There are various MST methods that are employed by researchers and these could lead to variations in obtained results [6].

Significance of Medicinal Plants as Source of New Drugs/ Antimicrobial Agents

Chemical substances derived from medicinal plants and other natural sources have been used to treat human diseases since the dawn of medicine. Clinical, pharmacological and chemical studies of these chemical substances, which were primarily derived from plants, were the basis of most early medicines such as aspirin, digitoxin, morphine, quinine, and pilocarpine [7]. Biological activity guided isolation has been the most reliable method for the discovery of important novel drugs from medicinal plants. A fair share of new potential drugs especially in areas of anticancer, antihypertensive, anti-infective, immune-suppression and neurological disease management is still provided by natural products despite competition with other methods of drug discovery [8]. Biologically active compounds isolated from plant species used in herbal medicines have demanded great attention in recent times due to the side effects and the serious issues of resistance that pathogenic microorganisms develop against conventional antibiotics [8]. Antimicrobials of plant origin are quite effective in the treatment of infectious diseases while simultaneously alleviating the numerous side effects often associated with synthetic antimicrobials [2].

Terrestrial plants offer a unique and renewable resource for the discovery of new drugs and biological entities due to the biological and structural diversity or heterogeneity of their constituents [9]. They have played an imperative role in the discovery of new chemical entities for drug discovery and development. Plant-derived drugs also serve as lead compounds which can further be optimized by synthetic means [10]. Medicinal plants are undoubtedly among the most perfect “natural laboratories” for the synthesis of various molecules ranging from simple to highly complex chemical structures. Only 5-10 percent of around 250,000 higher terrestrial plants in existence have been chemically and pharmacologically investigated in systematic fashion. There is an obvious need for improvement on part of the assessment tools and techniques used to explore this natural treasure [11,12]. A summary of few antimicrobial bioactive compounds obtained from medicinal plants is presented in Table 1.